IGF-1 LR3

IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is a modified, more potent version of the naturally occurring IGF-1 peptide. The modification involves replacing the glutamic acid at position 3 with arginine (R3) and adding a 13-amino-acid extension at the N-terminus (Long), which dramatically reduces its binding to IGF binding proteins (IGFBPs). In the body, natural IGF-1 is largely bound to IGFBPs which limit its bioavailability and activity — approximately 98% of circulating IGF-1 is protein-bound. IGF-1 LR3's reduced IGFBP binding means it remains active in the bloodstream for much longer (half-life of 20-30 hours vs.

12-15 hours for standard IGF-1) and has approximately three times the potency of regular IGF-1. IGF-1 is the primary mediator of growth hormone's anabolic effects — when GH is released, the liver produces IGF-1, which then drives muscle growth, fat metabolism, and tissue repair. IGF-1 LR3 directly activates the IGF-1 receptor (IGF-1R), triggering the PI3K/Akt and MAPK/ERK signaling cascades that promote protein synthesis, cell proliferation, and inhibit apoptosis. It is one of the most potent anabolic peptides available, capable of promoting muscle hyperplasia (creation of new muscle cells) rather than just hypertrophy (enlargement of existing cells).

It also enhances nutrient partitioning, directing calories toward muscle tissue and away from fat storage. Due to its potency, IGF-1 LR3 requires careful dosing and is typically used in shorter cycles.